Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(50.0%)
Phase 2
2(33.3%)
Phase 1
1(16.7%)
6Total
N/A(3)
Phase 2(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT01907269Not ApplicableCompleted

A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care

Role: collaborator

NCT02778087Not ApplicableTerminated

Mirror Therapy After Stroke: A Dosing Study

Role: collaborator

NCT00668941Phase 2Unknown

Cyclic Versus Daily Teriparatide on Bone Mass

Role: lead

NCT00005006Phase 2Completed

Parathyroid Hormone (PTH) With Alendronate for Osteoporosis

Role: lead

NCT01545986Not ApplicableCompleted

A Comparative Analysis of Two Types of Exercise on Outcomes Following Total Knee Arthroplasty

Role: lead

NCT00428480Phase 1Completed

Walking Study for Stroke Rehabilitation

Role: collaborator

All 6 trials loaded